Jazz Pharmaceuticals PLC (NAS:JAZZ)
$ 121.58 -0.01 (-0.01%) Market Cap: 7.35 Bil Enterprise Value: 10.93 Bil PE Ratio: 17.12 PB Ratio: 1.76 GF Score: 85/100

Jazz Pharmaceuticals PLC at Cowen and Company Health Care Conference Transcript

Mar 12, 2019 / 04:00PM GMT
Release Date Price: $133.85 (+0.64%)
Kenneth Charles Cacciatore
Cowen and Company, LLC, Research Division - MD and Senior Research Analyst

Okay. Thanks, everyone. I appreciate Matt and Kathee coming all the way from the West Coast to join us. So thanks again for doing this. We're really, really appreciative. And so I don't know if you wanted to start with any introductory comments, or we can just get into Q&A. And anyone in the audience, obviously, just raise your hand during it and we'll let you chime in as well.

Matthew P. Young
Jazz Pharmaceuticals plc - Executive VP & CFO

I don't know, Ken, do you have enough questions for us?

Kenneth Charles Cacciatore
Cowen and Company, LLC, Research Division - MD and Senior Research Analyst

I've got questions. If you want to, we'll just get into it.

Matthew P. Young
Jazz Pharmaceuticals plc - Executive VP & CFO

Sure. Yes. Very good.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot